October 26, 2021 Comments Off on New patent for Gilead Sciences drug VEMLIDY Posted in: Patent Added Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Gilead Sciences drug VEMLIDY appeared first on DrugPaten…
October 26, 2021 Comments Off on New patent for Hisamitsu drug SECUADO Posted in: Patent Added Annual Drug Patent Expirations for SECUADO Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Hisamitsu drug SECUADO appeared first on DrugPa…
